Health Care Access and Use Among Adults with Diabetes During the COVID-19 Pandemic — United States, February–March 2021
暂无分享,去创建一个
C. Czeisler | M. Weaver | M. Howard | K. Bullard | Mark E Czeisler | Catherine E. Barrett | S. Rajaratnam | Karen R. Siegel
[1] D. Hessler,et al. Cross-national comparison of psychosocial well-being and diabetes outcomes in adults with type 1 diabetes during the COVID-19 pandemic in US, Brazil, and Iran , 2021, Diabetology & Metabolic Syndrome.
[2] In-kyu Lee,et al. Impact of urgently initiated tele-prescription due to COVID-19 on glycemic control in patients with type 2 diabetes , 2021, The Korean journal of internal medicine.
[3] S. Gitelman,et al. Youth with Type 1 Diabetes had Improvement in Continuous Glucose Monitoring Metrics During the COVID-19 Pandemic. , 2021, Diabetes technology & therapeutics.
[4] A. Salonia,et al. Diabetes is most important cause for mortality in COVID-19 hospitalized patients: Systematic review and meta-analysis , 2021, Reviews in Endocrine and Metabolic Disorders.
[5] A. Alfadda,et al. The impact of a prolonged lockdown and use of telemedicine on glycemic control in people with type 1 diabetes during the COVID-19 outbreak in Saudi Arabia , 2021, Diabetes Research and Clinical Practice.
[6] A. Fryer,et al. Impact of the UK COVID‐19 pandemic on HbA1c testing and its implications for diabetes diagnosis and management , 2020, International journal of clinical practice.
[7] D. Klonoff,et al. Association Between Achieving Inpatient Glycemic Control and Clinical Outcomes in Hospitalized Patients With COVID-19: A Multicenter, Retrospective Hospital-Based Analysis , 2020, Diabetes Care.
[8] G. Alonso,et al. Increased DKA at presentation among newly diagnosed type 1 diabetes patients with or without COVID‐19: Data from a multi‐site surveillance registry , 2020, Journal of diabetes.
[9] W. Polonsky,et al. The early impact of the COVID-19 pandemic on adults with type 1 or type 2 diabetes: A national cohort study , 2020, Journal of Diabetes and its Complications.
[10] K. Khunti,et al. Risk factors for COVID-19-related mortality in people with type 1 and type 2 diabetes in England: a population-based cohort study , 2020, The Lancet Diabetes & Endocrinology.